Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Leila R. Martins, Yasser Perera, Paulo Lúcio, Maria G. Silva, Silvio E. Perea, João T. Barata

Journal title: Oncotarget

Journal number: 19492553

Journal publisher: Impact Journals

Published year: 2014

Published pages: 258-263

DOI identifier: 10.18632/oncotarget.1513

ISSN: 1949-2553